For example, loss-of-function mutations in LRP5 have been reported to cause the autosomal recessive human disease osteoporosis-pseudoglioma syndrome (OPPG), which leads to significant reduction of BMDs, and are more susceptible to skeletal fracture and deformity [77–79]. Here, LRP5 is linked to osteoporosis-pseudoglioma syndrome.